Early cardiac involvement in an infantile Sandhoff disease case with novel mutations

Hsiu-Fen Lee1, Ching-Shiang Chi2, Chi-Ren Tsai3

  • 1Department of Pediatrics, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Brain & Development
|October 5, 2016
PubMed

Insights

Cardiac involvement can precede neurological symptoms in infantile Sandhoff disease, a rare lysosomal storage disorder. Early cardiac evaluation is crucial for diagnosing this condition in infants.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Infantile Sandhoff disease typically presents with hepatosplenomegaly.
  • Cardiac involvement is an exceptionally rare manifestation.

Observation:

  • A 14-month-old infant presented with early-onset cardiomegaly and mitral regurgitation.
  • Neurological regression occurred after infection, with MRI showing characteristic brain signal changes and fundus examination revealing cherry-red spots.
  • Reduced beta-hexosaminidase B (HEXB) activity and novel HEXB gene mutations were identified.

Findings:

  • The patient exhibited significant cardiac abnormalities, including left atrial and ventricular dilation.
  • Genetic analysis revealed two novel mutations in the HEXB gene.
  • Lysosomal enzymatic assays confirmed a marked reduction in HEXB activity.

Implications:

  • Cardiac manifestations may precede neurological symptoms in infantile Sandhoff disease.
  • Metabolic cardiomyopathies in infants should consider Sandhoff disease in their differential diagnosis.
  • This case highlights the importance of comprehensive evaluation in suspected lysosomal storage disorders.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
702
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
748
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K